23-25
Nov
2026
CPHI India 2026
IICC, Yashobhoomi, Dwarka, Delhi
2J44

Cadchem Laboratories Ltd

About Cadchem Laboratories Ltd

Cadchem Laboratories Ltd is a leading API manufacturing company having Korean MFDS, WHO-GMP approvals. CLL's focus has been on cardio, neuro and anti-diabetic segments and offering its products in global markets. 

We have CEP of Clopidogrel Bisulphate Form II   and Leviteracetam .


Other planned API for CEP filling includes Rosuvastatiun Calcium /  Rifaxamin and Brivaracetam .


We are also manufacturing Citicoline sodium , Benfothiamine and Rivaroxaban .


API under planning includes Ticagrelor / Quetiapine/Apixaben/Empagliflozin/dapagliglozin/Ketrilac Tromethamine .





Meet us at

  • CPHI India 2026

    IICC, Yashobhoomi, Dwarka, Delhi
    23 Nov 2026 - 25 Nov 2026
  • Country/Region:
    India
  • On CPHI since:
    2019
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
Primary activities
API Producer
Contact info
  • Plot no 1060, Industrial Area, Phase 2,, Chandigarh, India

Products from Cadchem Laboratories Ltd (6)

Cadchem Laboratories Ltd Resources (1)